Navigation Links
Hopkins researchers release genome data on autism
Date:10/23/2007

Researchers at Johns Hopkins McKusick-Nathans Institute of Genetic Medicine today are releasing newly generated genetic data to help speed autism research. The Hopkins data, coordinated with a similar data release from the Autism Consortium, aims to help uncover the underlying hereditary factors and speed the understanding of autism by encouraging scientific collaboration. These data provide the most detailed look to date at the genetic variation patterns in families with autism.

Autism is a difficult enough genetic mystery for which we need all of the best minds and approaches to help unravel the role of genes in this neuropsychiatric illness, says Aravinda Chakravarti, Ph.D., director of the Center for Complex Disease Genomics at Hopkins.

Chakravarti and his team analyzed whole genomes from 1,250 autistic individuals, their siblings and parents; these samples were collected across the United States by many researchers under the aegis of the National Institute of Mental Health, part of the National Institutes of Health. Mark Daly, Ph.D., a senior associate member of the Broad Institute of Massachusetts Institute of Technology and Harvard, is part of the Autism Consortium which released data acquired collected similarly from 3,000 individuals who are either affected by autism spectrum disorders (ASD) or are family members of individuals with autism.

Were releasing raw genotype data so that other qualified researchers can take a look at it even as were still beginning our own analysis, says Daly.

It is really something of a landmark to have pre-publication data from our laboratories available to autism researchers. We are doing so in the spirit of the human genome project where such data releases were critical to progress long before final results were available. We are carefully looking at our collaborative findings as we continue to search for definitive information about which genes are important in causing autism spectrum disorders, says Chakravarti, who has collaborated with Daly for many years. We hope to identify the most likely candidates over the next few months.

The number of individuals diagnosed with autism spectrum disorders, which impair thinking, feeling, language skills and the ability to relate to others, has significantly increased in recent years. Although there is some uncertainty about the role that better recognition and diagnosis of disorders, as well as biological and environmental factors, play a role in this rise in ASD incidence, there is growing evidence that genes contribute significantly to autism spectrum disorders. The release of the data from this screen is a significant step toward identifying those genes.

Autism spectrum disorders are extremely complex, and only through collaboration with researchers with many specialized areas of expertise will we gain an understanding of what makes some children susceptible, says Daly.

Todays release of genetic and phenotypic data on autism marks a significant achievement for the autism research community, says Thomas Insel, Ph.D., director of the National Institute for Mental Health. Progress in finding the causes of and cures for autism spectrum disorders rests in large part on improving the rapid access and sharing of data and resources.


'/>"/>

Contact: Audrey Huang
audrey@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
Source:Eurekalert

Related medicine news :

1. John Hopkins CGHH program provides Global Health education
2. A new study by John Hopkins University proposes formula for good health
3. Genetic Experts of Hopkins Assists In Identifying Hurricane Katrina Victims
4. Craig Newschaffer of Johns Hopkins Bloomberg School of Public Health in Baltimore.
5. Diabetes - New Treatment Approach At John Hopkins
6. Cardiovascular Diseases in India To be Studied Jointly By John Hopkins And Apollo Hospitals
7. John Hopkins Develops An Online Tool To Help In Research Of Certain Rare Diseases
8. Johns Hopkins Computer Scientists Unravel Language Of Surgery
9. Gene Hunters at Johns Hopkins Close In On Lou Gehrigs Disease
10. Johns Hopkins Medicine Trustees Support Smoking Ban In Public Spaces
11. John Hopkins Hospitals- Now at Tokyo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... ... team BioCellection won the $30,000 Perlman Grand Prize of the 2016 Wharton Business ... Award, the Michelson People’s Choice Award, and the Committee Award for Most ‘Wow ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... Canadian Celiac Association (CCA), is pleased to announce the launch of the ... nutritional articles, recipes, and more. The purpose of the GFCP Scoop ...
(Date:4/29/2016)... ... April 29, 2016 , ... New York City based oral and maxillofacial surgeon Dr. ... very effective way to treat obstructive sleep apnea. Dr. Jamali is proud to offer this ... procedure that involves one or both jaw bones. This surgery is performed to correct the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market ... funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... and accelerate its technology and product roadmap. , “Jvion is experiencing ...
(Date:4/29/2016)... ... 2016 , ... CURE Media Group , the nation’s ... today announced that Lynne Malestic, RN, of Eisenhower Lucy Curci Cancer Center in ... Oncology Nursing , which honors nurses who have dedicated their careers to helping ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
(Date:4/28/2016)... , April 28, 2016 ... Review, H1 2016" is a report that provides ... helps strengthen R&D pipelines by identifying new targets ... Company Profiles discussed in this H1 ... Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., ...
(Date:4/27/2016)... 27, 2016   ... in Recurring Consumable Sales  Clinical sales grow ... Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the ... for the first quarter ended March 31, 2016 and ... of its commercial strategy. First Quarter 2016 ...
Breaking Medicine Technology: